drugset / Trial / NCT01003288

Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen

NCT01003288

NaSingle-groupOpen-labelPrevention

Summary

Haukeland University Hospital has approximately 8000 employees many of whom will be in the front line to receive the pandemic A/H1N1 vaccine. We propose to conduct a safety and immunogenicity study in these subjects

Timeline

Start
2009-10
Primary completion
2010-01
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pandemrix Vaccine 3.75 ug Other
Subject Pandemrix Vaccine 0.5 ml Other

Indications

No indication recorded.